Section 32 logo

Section 32

Crunchbase
Pitchbook
Crunchbase

Deals on record

5

Common Fundraising Type

Series B

SandboxAQ logo
SandboxAQ

Quantum computing

T. Rowe Price Associates logo
US Innovative Technology Fund logo
S32 logo
Rizvi Traverse logo
PQV logo
Mumtalakat logo
IQT logo
Fred Alger Management logo

SandboxAQ develops quantum physics-based software for applications in life sciences, materials science, navigation, encryption, and cybersecurity.

Equity
$300M
12/18/2024
Article
TollBit logo
TollBit

Real-time payments

TollBit provides a platform for real-time payments between AI companies and publishers to help content creators monetize their data usage effectively.

Series A
$24M
10/22/2024
Article
Sunbird Bio logo
Sunbird Bio

Biotechnology

Polaris Partners logo
S32 logo
Eli Lilly and Company logo
EDBI logo
ClavystBio logo

Sunbird Bio develops a blood-based diagnostic platform for early and accurate detection of neurological disorders like Alzheimer’s and Parkinson’s disease.

Equity
$14M
10/16/2024
Article

Basecamp Research is a London-based startup developing an AI platform for biological insights by building a comprehensive database of primary-source biological data for applications in drug discovery and genetic medicine.

Series B
$60M
10/09/2024
Article
ROME Therapeutics logo
ROME Therapeutics

Biotechnology

Section 32 logo
Sanofi Ventures logo
Raycap logo
Mirae Asset Capital logo
Mass General Brigham Ventures logo
Luma Group logo
Johnson & Johnson Innovation-JJDC logo
GV logo

ROME Therapeutics is a biotechnology company that develops breakthrough medicines for serious diseases, with a focus on an inhibitor of LINE-1 reverse transcriptase for autoimmune diseases, using their proprietary data science platform to identify active repeat elements and assess their roles in disease.

Series B
$72M
09/12/2023
Article